| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-11 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-10 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-10 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
7e-09 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-09 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-07 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |